Clinical characteristics of 138 Chinese female patients with idiopathic hypogonadotropic hypogonadism

Objective To evaluate the clinical features of Chinese women with idiopathic hypogonadotropic hypogonadism (IHH). Methods We retrospectively reviewed the clinical characteristics, laboratory and imaging findings, therapeutic management and fertility outcomes of 138 women with IHH. All patients had been treated and followed up at an academic medical centre during 1990–2016. Results Among the 138 patients, 82 patients (59.4%) were diagnosed with normosmic IHH and 56 patients (40.6%) were diagnosed with Kallmann syndrome (KS). The patients with IHH experienced occasional menses (4.3%), spontaneous thelarche (45.7%) or spontaneous pubarche (50.7%). Women with thelarche had a higher percentage of pubarche (P < 0.001) and higher gonadotropin concentrations (P < 0.01). Olfactory bulb/sulci abnormalities were found during the magnetic resonance imaging (MRI) of all patients with KS. Most patients with IHH had osteopenia and low bone age. Among the 16 women who received gonadotropin-releasing hormone treatment, ovulation induction or assisted reproductive technology, the clinical pregnancy rate was 81.3% and the live birth rate was 68.8%. Conclusions The present study revealed that the phenotypic spectrum of women with IHH is broader than typical primary amenorrhoea with no secondary sexual development, including occasional menses, spontaneous thelarche or pubarche. MRI of the olfactory system can facilitate the diagnosis of KS. Pregnancy can be achieved after receiving appropriate treatment.

[1]  Guangbin Wang,et al.  Magnetic Resonance Imaging Findings in Kallmann Syndrome: 14 Cases and Review of the Literature , 2016, Journal of computer assisted tomography.

[2]  P. Macchia,et al.  Flavor perception test: evaluation in patients with Kallmann syndrome , 2016, Endocrine.

[3]  M. Maghnie,et al.  Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment , 2015, Nature Reviews Endocrinology.

[4]  M. Bianco,et al.  Bone involvement in males with Kallmann disease , 2015, Aging Clinical and Experimental Research.

[5]  M. Hauschild,et al.  TRANSITION IN ENDOCRINOLOGY: Hypogonadism in adolescence. , 2015, European journal of endocrinology.

[6]  Di Wu,et al.  Pulsatile GnRH Is Superior to hCG in Therapeutic Efficacy in Adolescent Boys With Hypogonadotropic Hypogonadodism. , 2015, The Journal of clinical endocrinology and metabolism.

[7]  G. Merlo,et al.  Kallmann’s syndrome and normosmic isolated hypogonadotropic hypogonadism: two largely overlapping manifestations of one rare disorder , 2014, Journal of Endocrinological Investigation.

[8]  R. Quinton,et al.  Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system. , 2014, The Journal of clinical endocrinology and metabolism.

[9]  A. Latronico,et al.  Approach to the patient with hypogonadotropic hypogonadism. , 2013, The Journal of clinical endocrinology and metabolism.

[10]  S. Nair,et al.  An objective olfactory evaluation and its correlation with magnetic resonance imaging findings in Asian Indian patients with idiopathic hypogonadotropic hypogonadism. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[11]  M. Palmert,et al.  Clinical review: Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. , 2012, The Journal of clinical endocrinology and metabolism.

[12]  A. Gunn,et al.  Treatment of infertility with hypogonadotropic hypogonadism: 10‐year experience in Auckland, New Zealand , 2012, The Australian & New Zealand journal of obstetrics & gynaecology.

[13]  A. Sonmez,et al.  Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. , 2012, Endocrine journal.

[14]  R. Doty,et al.  Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  D. Libri,et al.  New understandings of the genetic basis of isolated idiopathic central hypogonadism. , 2012, Asian journal of andrology.

[16]  R. Quinton,et al.  Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory , 2011, Trends in Endocrinology & Metabolism.

[17]  A. C. Santos,et al.  Quantitative Magnetic Resonance Imaging Evaluation of the Olfactory System in Kallmann Syndrome: Correlation with a Clinical Smell Test , 2011, Neuroendocrinology.

[18]  F. R. Arkoncel,et al.  A case of Kallmann syndrome , 2011, BMJ Case Reports.

[19]  J. Gusella,et al.  Expanding the phenotype and genotype of female GnRH deficiency. , 2011, The Journal of clinical endocrinology and metabolism.

[20]  L. Hudgins,et al.  Clues to an early diagnosis of Kallmann syndrome , 2010, American journal of medical genetics. Part A.

[21]  A. Genazzani,et al.  Hypoestrogenism in young women and its influence on bone mass density , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[22]  P. Chanson,et al.  Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships. , 2010, European journal of endocrinology.

[23]  P. Tonella,et al.  A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. , 2010, The Journal of clinical endocrinology and metabolism.

[24]  R. Auchus,et al.  Puberty in a case with novel 17-hydroxylase mutation and the putative role of estrogen in development of pubic hair. , 2008, European journal of endocrinology.

[25]  P. McGovern,et al.  A Review of Kallmann Syndrome: Genetics, Pathophysiology, and Clinical Management , 2008, Obstetrical & gynecological survey.

[26]  C. Leães,et al.  Two cases of Kallmann syndrome associated with empty sella , 2007, Pituitary.

[27]  D. Bick,et al.  Clinical and molecular characterization of a large sample of patients with hypogonadotropic hypogonadism. , 2006, Fertility and sterility.

[28]  V. Sawlani,et al.  MRI findings in Kallmann syndrome. , 2004, Neurology India.

[29]  W. Crowley,et al.  The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. , 2002, The Journal of clinical endocrinology and metabolism.

[30]  R. Quinton,et al.  Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization* , 2001, Clinical endocrinology.

[31]  R. Quinton,et al.  Routine neuroimaging in classical isolated gonadotrophin deficiency is of limited clinical value , 2001, Clinical endocrinology.

[32]  W. Crowley,et al.  Genetics of hypogonadotropic hypogonadism , 2000, Journal of endocrinological investigation.

[33]  R. Quinton,et al.  The neuroradiology of Kallmann's syndrome: a genotypic and phenotypic analysis. , 1996, The Journal of clinical endocrinology and metabolism.

[34]  T. Vogl,et al.  Kallman syndrome versus idiopathic hypogonadotropic hypogonadism at MR imaging. , 1994, Radiology.

[35]  Paul Shaman,et al.  University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic , 1984, The Laryngoscope.